BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
Response to oxidative stress
,
Inflammatory disorder
,
Kidney
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ucn 01
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
TP53I3
AHRR
CXCL1
CYR61
ALDH1A3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FISCHER_DREAM_TARGETS
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS
PUJANA_CHEK2_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
HCT116 colon carcinoma cells - gene expression profiles in response to Chk1 inhibition or cisplatin
Explore Curated Studies Results
Literature
Most Relevant Literature
The structural basis for high affinity binding of α1-acid glycoprotein to the potent antitumor compo…
Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells agai…
Caspase-9 mediates Puma activation in UCN-01-induced apoptosis.
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by …
UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA dam…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase II Study of UCN-01 in Metastatic Melanoma
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or…
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ